Infection-induced 5′-half molecules of tRNAHisGUG activate Toll-like receptor 7

0301 basic medicine 570 QH301-705.5 THP-1 Cells Endosomes exosomes RNA, Transfer, His pattern-recognition NF-κB noncoding RNA Extracellular Vesicles 03 medical and health sciences RNA, Transfer Medicine and Health Sciences Humans Biology (General) Macrophages 500 500 Naturwissenschaften und Mathematik::570 Biowissenschaften; Biologie::570 Biowissenschaften; Biologie Immunity, Innate macrophages 3. Good health Gene Expression Regulation Toll-Like Receptor 7 antiviral responses transfer-RNA fragments identification Research Article
DOI: 10.1371/journal.pbio.3000982 Publication Date: 2020-12-17T19:17:01Z
ABSTRACT
Toll-like receptors (TLRs) play a crucial role in the innate immune response. Although endosomal TLR7 recognizes single-stranded RNAs, their endogenous RNA ligands have not been fully explored. Here, we report 5′-tRNA half molecules as abundant activators of TLR7. Mycobacterial infection and accompanying surface TLR activation up-regulate the expression of 5′-tRNA half molecules in human monocyte-derived macrophages (HMDMs). The abundant accumulation of 5′-tRNA halves also occur in HMDM-secreted extracellular vehicles (EVs); the abundance of EV-5′-tRNAHisGUGhalf molecules is >200-fold higher than that of the most abundant EV-microRNA (miRNA). Sequence identification of the 5′-tRNA halves using cP-RNA-seq revealed abundant and selective packaging of specific 5′-tRNA half species into EVs. The EV-5′-tRNAHisGUGhalf was experimentally demonstrated to be delivered into endosomes in recipient cells and to activate endosomal TLR7. Up-regulation of the 5′-tRNA half molecules was also observed in the plasma of patients infected withMycobacterium tuberculosis. These results unveil a novel tRNA-engaged pathway in the innate immune response and assign the role of “immune activators” to 5′-tRNA half molecules.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (91)
CITATIONS (63)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....